GTE vs INR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GTE exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a critical liquidity position with a current ratio of 0.60. Despite a speculative price surge over the last year, the company is plagued by negative profit margins (-32.36%), high leverage (Debt/Equity 3.17), and collapsing earnings growth. The disconnect between the current price ($8.80) and the analyst target price ($6.49) suggests the stock is significantly overvalued relative to its deteriorating fundamentals. The combination of operational losses and poor health scores indicates a high-risk profile.
INR presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but mediocre financial health. While the stock is fundamentally undervalued based on the Graham Number ($19.89) and Price-to-Book ratio (0.82), this is offset by extreme earnings volatility and a significant disconnect between revenue growth and bottom-line consistency. The massive disparity between the Graham Number and the growth-based Intrinsic Value ($6.23) suggests a high-risk profile where current pricing relies on defensive assets rather than sustainable growth. Furthermore, heavy insider selling by the CFO creates a bearish overhang despite strong analyst recommendations.
Compare Another Pair
Related Comparisons
GTE vs INR: Head-to-Head Comparison
This page compares Gran Tierra Energy Inc. (GTE) and Infinity Natural Resources, Inc. (INR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.